Gene testing and digital twins for high cholesterol in Emiratis
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This study uses whole genome sequencing and digital twin technology to better understand and manage very high cholesterol in Emirati adults. It aims to identify genetic causes and personalize treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an Emirati national between 18 and 55 years old.
- You have had at least two LDL (bad) cholesterol tests above 190 mg/dL (or 5.0 mmol/L) in the past year.
- You have not taken cholesterol-lowering medication in the last 3 months.
- You do not have a known diagnosis of familial hypercholesterolemia or other serious health conditions.
- You are not pregnant and have no untreated anxiety or depression.
- You can read and speak English or Arabic.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial focuses on people referred to a cholesterol (lipid) clinic to help identify inherited high cholesterol. It tests an “interpretive comment” approach to nudge detection—meaning it may help clinicians recognize who is most likely to have familial hypercholesterolemia.
This study uses a 'cascade testing' approach, where family members of people with familial hypercholesterolemia (FH), a genetic condition causing very high cholesterol, are tested to see if they also have it. The goal is to identify and test at-risk relatives early so they can get treatment to prevent heart problems.
This trial tests a one-time gene therapy to lower extremely high cholesterol in people with a rare inherited condition. It may help reduce heart attack risk in those who haven't responded to standard treatments.
This trial focuses on people with familial hypercholesterolemia (FH), an inherited condition that causes very high cholesterol. It aims to better understand and manage severe cholesterol problems that raise heart risk, especially in families.
This study tests a new injection called ART002g1 for people with an inherited form of high cholesterol (heterozygous familial hypercholesterolemia). The goal is to see if it is safe and can help lower cholesterol levels.
This study aims to find and help people with very high cholesterol, which can run in families. If you or your child have high cholesterol, this study may help you understand your risk and get the right care.
Hear when a new Hypercholesterolemia, Autosomal Dominant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.